Anika osteoarthritis knee treatment study completed
This article was originally published in Clinica
Executive Summary
Anika Therapeutics has completed a clinical study of its Orthovisc treatment for osteoarthritis of the knee. The company's president and CEO, J Melville Engle, said that based on the promising results Anika would file a pre-market approval application with the FDA later this year, said president.